PIGW-related glycosylphosphatidylinositol deficiency: Description of a new patient and review of the literature.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
06 2020
Historique:
received: 26 11 2019
revised: 20 02 2020
accepted: 02 03 2020
pubmed: 22 3 2020
medline: 29 1 2021
entrez: 22 3 2020
Statut: ppublish

Résumé

Inherited glycosylphosphatidylinositol (GPI) deficiencies are a group of clinically and genetically heterogeneous conditions belonging to the congenital disorders of glycosylation. PIGW is involved in GPI biosynthesis and modification, and biallelic pathogenic variants in this gene cause autosomal recessive GPI biosynthesis defect 11. Only five patients and two fetuses have been reported in the literature thus far. Here we describe a new patient with a novel homozygous missense variant in PIGW, who presented with hypotonia, severe intellectual disability, early-onset epileptic seizures, brain abnormalities, nystagmus, hand stereotypies, recurrent respiratory infections, distinctive facial features, and hyperphosphatasia. Our report expands the phenotype of GPI biosynthesis defect 11 to include stereotypies and recurrent respiratory infections. A detailed and long-term analysis of the electroclinical characteristics and review of the literature suggest that early-onset epileptic seizures are a key manifestation of GPI biosynthesis defect 11. West syndrome and focal-onset epileptic seizures are the most common seizure types, and the fronto-temporal regions may be the most frequently involved areas in these patients.

Identifiants

pubmed: 32198969
doi: 10.1002/ajmg.a.61555
doi:

Substances chimiques

Glycosylphosphatidylinositols 0
Membrane Proteins 0
Acyltransferases EC 2.3.-
PIGW protein, human EC 2.3.-.-

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

1477-1482

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

Bellai-Dussault, K., Nguyen, T. T. M., Baratang, N. V., Jimenez-Cruz, D. A., & Campeau, P. M. (2019). Clinical variability in inherited glycosylphosphatidylinositol deficiency disorders. Clinical Genetics, 95(1), 112-121. https://doi.org/10.1111/cge.13425
Chiyonobu, T., Inoue, N., Morimoto, M., Kinoshita, T., & Murakami, Y. (2014). Glycosylphosphatidylinositol (GPI) anchor deficiency caused by mutations in PIGW is associated with West syndrome and hyperphosphatasia with mental retardation syndrome. Journal of Medical Genetics, 51(3), 203-207. https://doi.org/10.1136/jmedgenet-2013-102156
Cogliati, F., Giorgini, V., Masciardi, M., Bonati, M.T., Marchi, M., Cracco, I., … Russo, S. (2019). Pathogenic variants in STXBP1 and in genes for GABAa receptor subunits cause atypical Rett/Rett-like phenotypes. International Journal of Molecular Sciences, 20(15), pii: E3621. doi: https://doi.org/10.3390/ijms20153621.
Edvardson, S., Murakami, Y., Nguyen, T. T., Shahrour, M., St-Denis, A., Shaag, A., … Elpeleg, O. (2017). Mutations in the phosphatidylinositol glycan C (PIGC) gene are associated with epilepsy and intellectual disability. Journal of Medical Genetics, 54(3), 196-201. https://doi.org/10.1136/jmedgenet-2016-104202
Foskett, G. K., Engleman, E., Klotz, J., Choi, O., Tolentino, L., Kochhar, A., … Stevenson, D. A. (2018). Use of flow cytometry for diagnosis of epilepsy associated with homozygous PIGW variants. Pediatric Neurology, 85, 67-70. https://doi.org/10.1016/j.pediatrneurol.2018.05.010
Fu, L., Liu, Y., Chen, Y., Yuan, Y., & Wei, W. (2019). Mutations in the PIGW gene associated with hyperphosphatasia and mental retardation syndrome: A case report. BMC Pediatrics, 19(1), 68. https://doi.org/10.1186/s12887-019-1440-8
Hill, A., DeZern, A. E., Kinoshita, T., & Brodsky, R. A. (2017). Paroxysmal nocturnal haemoglobinuria. Nature Reviews. Disease Primers, 3, 17028. https://doi.org/10.1038/nrdp.2017.28
Hogrebe, M., Murakami, Y., Wild, M., Ahlmann, M., Biskup, S., Hörtnagel, K., … Marquardt, T. (2016). A novel mutation in PIGW causes glycosylphosphatidylinositol deficiency without hyperphosphatasia. American Journal of Medical Genetics Part A, 170(12), 3319-3322. https://doi.org/10.1002/ajmg.a.37950
Iascone, M., Sana, M. E., Pezzoli, L., Bianchi, P., Marchetti, D., Fasolini, G., … Ferrazzi, P. (2012). Extensive arterial tortuosity and severe aortic dilation in a newborn with an EFEMP2 mutation. Circulation, 126(23), 2764-2768. https://doi.org/10.1161/CIRCULATIONAHA.112.119883
Jaeken, J., Hennet, T., Matthijs, G., & Freeze, H. H. (2009). CDG nomenclature: Time for a change! Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1792(9), 825-826. https://doi.org/10.1016/j.bbadis.2009.08.005
Jaeken, J., & Péanne, R. (2017). What is new in CDG? Journal of Inherited Metabolic Disease, 40(4), 569-586. https://doi.org/10.1007/s10545-017-0050-6
Kinoshita, T., Fujita, M., & Maeda, Y. (2008). Biosynthesis, remodelling and functions of mammalian GPI-anchored proteins: Recent progress. Journal of Biochemistry, 144(3), 287-294. https://doi.org/10.1093/jb/mvn090
Knaus, A., Kortüm, F., Kleefstra, T., Stray-Pedersen, A., Đukić, D., Murakami, Y., … Kinoshita, T. (2019). Mutations in PIGU impair the function of the GPI Transamidase complex, causing severe intellectual disability, epilepsy, and brain anomalies. The American Journal of Human Genetics, 105(2), 395-402. https://doi.org/10.1016/j.ajhg.2019.06.009
Meier, N., Bruder, E., Lapaire, O., Hoesli, I., Kang, A., Hench, J., … Filges, I. (2019). Exome sequencing of fetal anomaly syndromes: Novel phenotype-genotype discoveries. European Journal of Human Genetics, 27(5), 730-737. https://doi.org/10.1038/s41431-018-0324-y
Murakami, Y., Nguyen, T. T. M., Baratang, N., Raju, P. K., Knaus, A., Ellard, S., … Kamei, A. (2019). Mutations in PIGB cause an inherited GPI biosynthesis defect with an axonal neuropathy and metabolic abnormality in severe cases. The American Journal of Human Genetics, 105(2), 384-394. https://doi.org/10.1016/j.ajhg.2019.05.019
Murakami, Y., Siripanyapinyo, U., Hong, Y., Kang, J. Y., Ishihara, S., Nakakuma, H., … Kinoshita, T. (2003). PIG-W is critical for inositol acylation but not for flipping of glycosylphosphatidylinositol-anchor. Molecular Biology of the Cell, 14(10), 4285-4295. https://doi.org/10.1091/mbc.E03-03-0193
Nguyen, T. T. M., Murakami, Y., Wigby, K. M., Baratang, N. V., Rousseau, J., St-Denis, A., … Campeau, P. M. (2018). Mutations in PIGS, encoding a GPI transamidase, cause a neurological syndrome ranging from fetal akinesia to epileptic encephalopathy. American Journal of Human Genetics, 103(4), 602-611. https://doi.org/10.1016/j.ajhg.2018.08.014
Nykamp, K., Anderson, M., Powers, M., Garcia, J., Herrera, B., Ho, Y. Y., … Topper, S. (2017). Sherloc: A comprehensive refinement of the ACMG-AMP variant classification criteria. Genetics in Medicine, 19(10), 1105-1117. https://doi.org/10.1038/gim.2017.37
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., … Rehm, H. L. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405-424. https://doi.org/10.1038/gim.2015.30
Shumiloff, N. A., Lam, W. M., & Manasco, K. B. (2013). Adrenocorticotropic hormone for the treatment of west syndrome in children. The Annals of Pharmacotherapy, 47(5), 744-754. https://doi.org/10.1345/aph.1R535
Sparks, S. E., & Krasnewich, D. M. (2017). Congenital disorders of N-linked glycosylation and multiple pathway overview. In GeneReviews®[Internet]. Seattle: University of Washington.
Schröder-Braunstein, J., & Kirschfink, M. (2019). Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical management. Molecular Immunology, 114, 299-311. https://doi.org/10.1016/j.molimm.2019.08.002
Yuan, X., Li, Z., Baines, A. C., Gavriilaki, E., Ye, Z., Wen, Z., … Brodsky, R. A. (2017). A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC model. PLoS One, 12(4), e0174074. https://doi.org/10.1371/journal.pone.0174074

Auteurs

Angela Peron (A)

Child Neuropsychiatry Unit-Epilepsy Center (Medical Genetics Clinic), ASST Santi Paolo e Carlo, San Paolo Hospital, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Department of Pediatrics, Division of Medical Genetics, University of Utah School of Medicine, Salt Lake City, Utah, USA.

Maria Iascone (M)

Laboratorio di Genetica Medica, ASST Papa Giovanni XXIII, Bergamo, Italy.

Elisabetta Salvatici (E)

Department of Pediatrics, ASST Santi Paolo e Carlo, San Paolo Hospital, Milan, Italy.

Benedetta Cavirani (B)

Child Neuropsychiatry Unit-Epilepsy Center, ASST Santi Paolo e Carlo, San Paolo Hospital, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Daniela Marchetti (D)

Laboratorio di Genetica Medica, ASST Papa Giovanni XXIII, Bergamo, Italy.

Silvia Corno (S)

Child Neuropsychiatry Unit-Epilepsy Center, ASST Santi Paolo e Carlo, San Paolo Hospital, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Aglaia Vignoli (A)

Child Neuropsychiatry Unit-Epilepsy Center, ASST Santi Paolo e Carlo, San Paolo Hospital, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH